Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) is now available.
Shanghai HeartCare Medical Technology Corporation Limited announced a non-compliance incident involving the disposal of shares by a director during a black-out period. The transactions, conducted by a partnership controlled by the director’s spouse, resulted in a reduction of the director’s shareholding interest. The company has taken steps to prevent future occurrences by reminding directors of compliance requirements and planning regular training sessions to enhance corporate governance practices.
The most recent analyst rating on (HK:6609) stock is a Hold with a HK$70.00 price target. To see the full list of analyst forecasts on Shanghai Heartcare Medical Technology Corp. Ltd. Class H stock, see the HK:6609 Stock Forecast page.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai HeartCare Medical Technology Corporation Limited is a company based in China, operating within the medical technology industry. It focuses on developing and providing advanced medical solutions, with a particular emphasis on cardiovascular health technologies.
Average Trading Volume: 210,243
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.48B
Find detailed analytics on 6609 stock on TipRanks’ Stock Analysis page.